VIMTA LABS
Back to Balance Sheet
|
VIMTA LABS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹18 Cr | ₹19 Cr | ₹23 Cr | ₹25 Cr | ₹15 Cr |
What is the latest Total Non-Current Liabilities ratio of VIMTA LABS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹19 Cr |
| Mar2022 | ₹23 Cr |
| Mar2021 | ₹25 Cr |
| Mar2020 | ₹15 Cr |
How is Total Non-Current Liabilities of VIMTA LABS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹18 Cr | -2.45 | |
| Mar2023 | ₹19 Cr | -19.01 | |
| Mar2022 | ₹23 Cr | -6.78 | |
| Mar2021 | ₹25 Cr | 69.42 | |
| Mar2020 | ₹15 Cr | - | |
Compare Total Non-Current Liabilities of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹2,687.6 Cr | 0.9% | -1.6% | 24.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,086.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,616.0 Cr | -1.9% | -1.6% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,361.0 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| CIPLA | ₹120,713.0 Cr | -1.2% | -2% | 2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,881.0 Cr | -1.2% | 1.5% | -6.1% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | 0.9% |
-1.6% |
24.4% |
| SENSEX | -0.3% |
-1.1% |
7.8% |
You may also like the below Video Courses